Number of the records: 1  

Marizomib suppresses triple-negative breast cancer via proteasome and oxidative phosphorylation inhibition

  1. 1.
    SYSNO0534655
    TitleMarizomib suppresses triple-negative breast cancer via proteasome and oxidative phosphorylation inhibition
    Author(s) Raninga, P. (AU)
    Lee, A. (TW)
    Sinha, D. (AU)
    Dong, L.F. (AU)
    Datta, K. (AU)
    Lu, X. (AU)
    Kalita-de Croft, P. (AU)
    Dutt, M. (AU)
    Hill, M. M. (AU)
    Pouliot, N. M. (AU)
    Gowda, H. (AU)
    Kalimutho, M. (AU)
    Neužil, Jiří (BTO-N) RID
    Khanna, K. K. (AU)
    Source Title Theranostics. Roč. 10, č. 12 (2020), s. 5259-5275. - : Ivyspring International Publisher
    Document TypeČlánek v odborném periodiku
    Grant NV17-30138A GA MZd - Ministry of Health (MZ), CZ - Czech Republic
    Institutional supportBTO-N - RVO:86652036
    Languageeng
    CountryAU
    Keywords stem-cell * multiple-myeloma * single-agent * phase-ii * bortezomib
    URLhttps://www.thno.org/v10p5259.htm
    Permanent Linkhttp://hdl.handle.net/11104/0312839
     
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.